NTTS 2017

Metastatic cancer represents a spectrum of disease with subsets of patients defined as oligometastatic with a limited number of lesions and a typically less aggressive course. Localized therapy, including stereotactic body radiation therapy (SBRT), has been shown to improve progression free survival. Current studies are planned to examine the impact of SBRT on survival for oligometastatic patients. We will review the history, rationale, data, and future directions for the treatment of oligometastatic malignancies with radiation.